Showing results (51-60 of 96) with videos related to
Sort By:
Pageof 10
Kardiologiia|March 1, 1992
[Clinico-immunological aspects of idiopathic ventricular arrhythmia]A V Nikitin, A M Zemskov, V M Zemskov, et al.Klinicheskaia Meditsina|December 1, 1991
[Use of cryo-apheresis in the treatment of patients with cortisol-dependent bronchial asthma]A V Nikitin, S I Simvolokov, V P Baranov, et al.Laboratornoe Delo|January 1, 1989
[Significance of determining the phenotypes of blood serum haptoglobin in infectious-inflammatory lung diseases]A V Nikitin, L V Vasil'eva, V I Sidel'nikova, et al.The Journal of Physical Chemistry. A|November 4, 2016
Full-Dimensional Potential Energy and Dipole Moment Surfaces of GeH<sub>4</sub> Molecule and Accurate First-Principle Rotationally Resolved Intensity Predictions in the InfraredA V Nikitin, M Rey, A Rodina, et al.Vrachebnoe Delo|January 1, 1989
[Combined immunocorrection--a prospective method for treating secondary immunodeficiency]V G Perederiĭ, A M Zemskov, V M Provotorov, et al.Antibiotiki I Meditsinskaia Biotekhnologiia = Antibiotics and Medical Biotechnology|November 1, 1987
[Low-molecular immunomodulators of natural origin]L M Khurnova, L P Ivanitskaia, A V Nikitin, et al.Antibiotiki I Meditsinskaia Biotekhnologiia = Antibiotics and Medical Biotechnology|May 1, 1985
[Experimental multifactorial study of the effect of doxycycline and glucosaminylmuramyl dipeptide on the primary immunologic response to antigens of a tularemia vaccine strain]A V Nikitin, T M Andronova, L P Kovalenko, et al.Voenno-Meditsinskii Zhurnal|September 10, 2008
[Molecularly-genetic aspects of metabolic syndrome]N P Potekhin, V P Romanov, A V Nikitin, et al.Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|January 1, 1991
[Optimal combined use of rifampicin and immunomodulator of microbial origin in experimental Q-Rickettsia infection]A V Nikitin, N D Klimchuk, I P Fomina, et al.Antibiotiki I Meditsinskaia Biotekhnologiia = Antibiotics and Medical Biotechnology|October 1, 1985
[Effect of the combined use of rifampicin and a low-molecular immunomodulator of natural origin on the primary immune response to the antigens of a tularemia vaccinal strain]A V Nikitin, L P Ivanitskaia, L E Bodunkova, et al.Pageof 10